Sigma Healthcare

SIG

The current Sigma Healthcare (SIG) market capitalization is approximately A$33.81B, based on its latest share price and shares outstanding. Market capitalization represents the total market value of a company's equity and is calculated by multiplying the current stock price by the number of shares outstanding. As a result, Sigma Healthcare's market cap fluctuates with changes in its share price and share count. Last updated: December 31, 2025 at 11:37 PM Eastern Time

In the most recently reported quarter, Sigma Healthcare (SIG) generated A$920.16M in revenue, representing a +9.43% year over year change. Quarterly revenue results and expectations reflect underlying demand trends, pricing dynamics, product or service mix, seasonality, and broader macroeconomic conditions. Actual results may differ from consensus estimates as new information becomes available. Last updated: February 4, 2025 at 1:33 AM Eastern Time

In the most recently reported fiscal year, Sigma Healthcare (SIG) generated net income of A$529.91M, compared with A$541.01M in the prior fiscal year, representing a -2.05% year over year change. For the upcoming fiscal year, analyst consensus currently estimates net income of A$729.61M. Net income may be positive or negative and can fluctuate materially from year to year due to changes in operating performance, non-recurring or one-time items, accounting treatments, capital structure, and broader macroeconomic conditions. Last updated: February 4, 2025 at 1:33 AM Eastern Time

According to its latest quarterly filing, Sigma Healthcare (SIG) reported EBITDA of A$6.60M, representing a -55.42% year over year change. EBITDA is a non-GAAP measure and does not account for depreciation, amortization, interest expense, taxes, or capital expenditures. As a result, it should be considered alongside other financial metrics when assessing operating performance. Actual results may differ from estimates as company-specific or macroeconomic conditions evolve. Last updated: February 4, 2025 at 1:33 AM Eastern Time

Based on the latest available data, Sigma Healthcare (SIG) is currently trading at a last twelve months (LTM) P/E ratio of -647.58x. The P/E ratio reflects how much investors are willing to pay today for a dollar of earnings and can vary meaningfully over time due to changes in profitability, growth expectations, margin outlook, and earnings volatility. Last updated: December 31, 2025 at 10:11 PM Eastern Time

Sigma Healthcare (SIG) is currently scheduled to report its next earnings results on March 16, 2026. Earnings dates are subject to change and may be updated by the company with limited notice. Investors typically monitor upcoming earnings releases closely, as they can result in increased volatility depending on reported results, forward guidance, and management commentary. Last updated: December 31, 2025 at 11:37 PM Eastern Time

In the most recently reported quarter, Sigma Healthcare (SIG) revenue was A$920.16M. Earnings per share (EPS) for the quarter were A$0.00. Revenue and EPS surprises may be positive or negative and can influence near-term stock performance depending on expectations, forward guidance, and broader market and sector conditions. For a detailed history of analyst expectations versus reported results, view the full estimates vs. actuals track record here: 👉 Estimates vs. Actuals Last updated: February 4, 2025 at 1:33 AM Eastern Time

Analyst assessments of whether Sigma Healthcare (SIG) consensus price target is overvalued or undervalued are generally expressed relative to consensus valuation frameworks and price targets, rather than as an absolute judgment.Current share price: A$2.94Consensus price target: A$3.30Implied return: +12.21% An implied return above current levels indicates that, on average, analysts view the stock as trading below their estimated fair value. Conversely, an implied return below current levels suggests the stock may be fully valued or priced above consensus expectations. This content is for informational purposes only and does not constitute investment advice. Last updated: December 31, 2025 at 10:11 PM Eastern Time

Based on the latest available analyst coverage, Sigma Healthcare (SIG) currently carries a Outperform consensus rating. Analysts' average SIG price target is A$3.30. Relative to the current share price of A$2.94, this suggests a potential price change of approximately +12.21%. Analyst views are forward-looking estimates and should not be considered investment advice. Last updated: December 31, 2025 at 10:11 PM Eastern Time

Like other publicly traded stocks, Sigma Healthcare (SIG) shares are bought and sold on stock exchanges such as ASX and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for Sigma Healthcare (SIG) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.

At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add SIG to your watchlist.

Sigma Healthcare trades under the ticker symbol SIG on the ASX stock exchange. The ticker SIG is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.

Sigma Healthcare (SIG) operates in a highly competitive market with companies that often have different business models, geographic exposure, and end markets. While no two companies are identical, the following firms are generally considered the closest Sigma Healthcare (SIG) stock peers based on overlapping products, services, and competitive dynamics:Harvey Norman Holdings (HVN)JB Hi-Fi (JBH)EBOS Group (EBO)Domino's Pizza Enterprises (DMP)Metcash (MTS)Wesfarmers (WES)Coles Group (COL)Shenzhen Neptunus Bioengineering (000078)Vital KSK Holdings (3151)Woolworths Group (WOW) These peers may differ in size, business mix, financial profile, and strategic focus, but they are commonly referenced due to overlapping markets, customer segments, or competitive positioning relative to Sigma Healthcare.